Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.31 USD | -1.77% | +0.53% | -11.27% |
05-14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
05-13 | Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
UROGEN PHARMA LTD. | Bio Therapeutic Drugs | -1.77% | +0.53% | -11.27% | +36.23% | -60.92% | 481M |
- Stock Market
- Equities
- URGN Stock
- Charts UroGen Pharma Ltd.
- Relative Strength Chart